Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.79
-0.45 (-6.22%)
At close: Aug 14, 2026, 4:00 PM EDT
6.82
+0.03 (0.44%)
After-hours: Aug 14, 2026, 7:59 PM EDT
Ginkgo Bioworks Holdings Operating Metrics
| Period Ending | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Active Programs | 483.00 | 564.00 | 602.00 | 619.00 | 612.00 | 545.00 | 492.00 | 449.00 | - | - | - | ||||||||
| Active Programs Growth | -21.08% | 3.49% | 22.36% | 37.86% | 47.83% | 42.30% | 40.17% | 41.19% | - | - | - | ||||||||
| Active Customers | - | - | - | 85.00 | 81.00 | 82.00 | 82.00 | 80.00 | 76.00 | 63.00 | 60.00 | ||||||||
| Active Customers Growth | - | - | - | 6.25% | 6.58% | 30.16% | 36.67% | 48.15% | 76.74% | 75.00% | 87.50% |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cell Engineering | 95.01M | 113.99M | 132.75M | 141.53M | 187.24M | 184.31M | 173.97M | 166.16M | |||||||||||
| Cell Engineering Growth | -49.26% | -38.15% | -23.70% | -14.82% | 46.00% | 34.22% | 21.21% | -2.15% | |||||||||||
| Biosecurity Services | 16.85M | 27.32M | 37.41M | 39.07M | 43.57M | 53.10M | 53.07M | 51.79M | |||||||||||
| Biosecurity Services Growth | -61.33% | -48.55% | -29.51% | -24.56% | -12.14% | -1.82% | -32.80% | -50.10% |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biosecurity | -8.93M | -13.75M | -18.93M | -24.63M | -25.96M | -24.59M | -30.62M | -32.55M | |||||||||||
| Cell Engineering | -182.57M | -135.32M | -95.53M | -116.40M | -93.11M | -178.98M | -239.65M | -312.58M |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development | 215.61M | 222.77M | 243.77M | 270.02M | 277.68M | 358.53M | 424.06M | 464.72M | |||||||||||
| Research & Development Growth | -22.35% | -37.87% | -42.51% | -41.90% | -48.99% | -35.34% | -26.96% | -27.92% | |||||||||||
| General & Administrative | 159.57M | 172.08M | 183.29M | 194.57M | 201.91M | 224.92M | 246.16M | 278.09M | |||||||||||
| General & Administrative Growth | -20.97% | -23.49% | -25.54% | -30.03% | -34.41% | -34.59% | -36.07% | -33.35% |